Hepatic Glycogen Storage Diseases: Pathogenesis, Clinical Symptoms and Therapeutic Management

Overview

Journal Arch Med Sci

Specialty General Medicine

Date 2021 Mar 22

PMID 33747265

Citations 9

Authors

Edyta Szymanska

Dominika A Jozwiak-Dziecielewska

Joanna Gronek

Marta Niewczas

Wojciech Czarny

Dariusz Rokicki

Piotr Gronek

Affiliations

Soon will be listed here.

Abstract

Glycogen storage diseases (GSDs) are genetically determined metabolic diseases that cause disorders of glycogen metabolism in the body. Due to the enzymatic defect at some stage of glycogenolysis/glycogenesis, excess glycogen or its pathologic forms are stored in the body tissues. The first symptoms of the disease usually appear during the first months of life and are thus the domain of pediatricians. Due to the fairly wide access of the authors to unpublished materials and research, as well as direct contact with the GSD patients, the article addresses the problem of actual diagnostic procedures for patients with the suspected diseases. Knowledge and awareness of the problem among physicians seem insufficient, and research on the diagnosis and treatment of GSD is still ongoing, resulting in a heterogeneous GSD typology and a changing way of its diagnosis and treatment.

Citing Articles

Comparison Between the Impact of Diabetes Mellitus on Liver Diseases and Vice Versa Among Saudi and Egyptian Patients.

Mahmoud M, Ibrahim S, Shahien M, Alshammari A, Alenazi F, Alreshidi F Healthcare (Basel). 2025; 13(4).

PMID: 39997251 PMC: 11855539. DOI: 10.3390/healthcare13040376.

Liver at crossroads: unraveling the links between obesity, chronic liver diseases, and the mysterious obesity paradox.

Elsabaawy M Clin Exp Med. 2024; 24(1):240.

PMID: 39402270 PMC: 11473604. DOI: 10.1007/s10238-024-01493-y.

A Functional Human Glycogen Debranching Enzyme Encoded by a Synthetic Gene: Its Implications for Glycogen Storage Disease Type III Management.

Triggiani D, Demurtas O, Illiano E, Massa S, Pasquo A, Dionisi-Vici C Protein Pept Lett. 2024; 31(7):519-531.

PMID: 39021187 DOI: 10.2174/0109298665307430240628063339.

A case study of a liver transplant-treated patient with glycogen storage disease type Ia presenting with multiple inflammatory hepatic adenomas: an analysis of clinicopathologic and genetic data.

Wang A, Wu J, Yuan X, Liu J, Lu C BMC Med Genomics. 2024; 17(1):124.

PMID: 38711024 PMC: 11075316. DOI: 10.1186/s12920-024-01888-6.

Genetics of enzymatic dysfunctions in metabolic disorders and cancer.

Mahe M, Rios-Fuller T, Karolin A, Schneider R Front Oncol. 2023; 13:1230934.

PMID: 37601653 PMC: 10433910. DOI: 10.3389/fonc.2023.1230934.

References

Francke U, Darras B, Zander N, Kilimann M . Assignment of human genes for phosphorylase kinase subunits alpha (PHKA) to Xq12-q13 and beta (PHKB) to 16q12-q13. Am J Hum Genet. 1989; 45(2):276-82. PMC: 1683359. View

Paradas C, Akman H, Ionete C, Lau H, Riskind P, Jones D . Branching enzyme deficiency: expanding the clinical spectrum. JAMA Neurol. 2013; 71(1):41-7. PMC: 6148323. DOI: 10.1001/jamaneurol.2013.4888. View

Sliwinska A, Kasinska M, Drzewoski J . MicroRNAs and metabolic disorders - where are we heading?. Arch Med Sci. 2017; 13(4):885-896. PMC: 5507111. DOI: 10.5114/aoms.2017.65229. View

Burwinkel B, Shiomi S, Al Zaben A, Kilimann M . Liver glycogenosis due to phosphorylase kinase deficiency: PHKG2 gene structure and mutations associated with cirrhosis. Hum Mol Genet. 1998; 7(1):149-54. DOI: 10.1093/hmg/7.1.149. View

Kagalwalla A, Kagalwalla Y, Al Ajaji S, Gorka W, Ali M . Phosphorylase b kinase deficiency glycogenosis with cirrhosis of the liver. J Pediatr. 1995; 127(4):602-5. DOI: 10.1016/s0022-3476(95)70123-0. View

Jo Y, Chua Jr S . The brain-liver connection between BDNF and glucose control. Diabetes. 2013; 62(5):1367-8. PMC: 3636607. DOI: 10.2337/db12-1824. View

Kishnani P, Austin S, Arn P, Bali D, Boney A, Case L . Glycogen storage disease type III diagnosis and management guidelines. Genet Med. 2010; 12(7):446-63. DOI: 10.1097/GIM.0b013e3181e655b6. View

Kim H, Zheng Z, Walker P, Kapatos G, Zhang K . CREBH Maintains Circadian Glucose Homeostasis by Regulating Hepatic Glycogenolysis and Gluconeogenesis. Mol Cell Biol. 2017; 37(14). PMC: 5492176. DOI: 10.1128/MCB.00048-17. View

Shah K, ODell S . Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type 1a: a systematic review and meta-analysis. J Hum Nutr Diet. 2013; 26(4):329-39. DOI: 10.1111/jhn.12030. View

10.

Wang H, Wu K, Tsai C . Neuroglycopenia in an euglycaemic patient under intensive insulin therapy. Anaesth Intensive Care. 2011; 38(6):1137-8. View

11.

Nakai A, Shigematsu Y, Takano T, Kikawa Y, Sudo M . Uncooked cornstarch treatment for hepatic phosphorylase kinase deficiency. Eur J Pediatr. 1994; 153(8):581-3. DOI: 10.1007/BF02190663. View

12.

Burwinkel B, Tanner M, Kilimann M . Phosphorylase kinase deficient liver glycogenosis: progression to cirrhosis in infancy associated with PHKG2 mutations (H144Y and L225R). J Med Genet. 2000; 37(5):376-7. PMC: 1734590. DOI: 10.1136/jmg.37.5.376. View

13.

Clayton P . Diagnosis of inherited disorders of liver metabolism. J Inherit Metab Dis. 2003; 26(2-3):135-46. DOI: 10.1023/a:1024429032116. View

14.

Shen J, Chen Y . Molecular characterization of glycogen storage disease type III. Curr Mol Med. 2002; 2(2):167-75. DOI: 10.2174/1566524024605752. View

15.

Brushia R, Walsh D . Phosphorylase kinase: the complexity of its regulation is reflected in the complexity of its structure. Front Biosci. 1999; 4:D618-41. DOI: 10.2741/brushia. View

16.

Lucchiari S, Fogh I, Prelle A, Parini R, Bresolin N, Melis D . Clinical and genetic variability of glycogen storage disease type IIIa: seven novel AGL gene mutations in the Mediterranean area. Am J Med Genet. 2002; 109(3):183-90. DOI: 10.1002/ajmg.10347. View

17.

Carriere C, Jonic S, Mornon J, Callebaut I . 3D mapping of glycogenosis-causing mutations in the large regulatory alpha subunit of phosphorylase kinase. Biochim Biophys Acta. 2008; 1782(11):664-70. DOI: 10.1016/j.bbadis.2008.09.011. View

18.

Hochuli M, Christ E, Meienberg F, Lehmann R, Krutzfeldt J, Baumgartner M . Alternative nighttime nutrition regimens in glycogen storage disease type I: a controlled crossover study. J Inherit Metab Dis. 2015; 38(6):1093-8. DOI: 10.1007/s10545-015-9864-2. View

19.

Correia C, Bhattacharya K, Lee P, Shuster J, Theriaque D, Shankar M . Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib. Am J Clin Nutr. 2008; 88(5):1272-6. PMC: 3808112. DOI: 10.3945/ajcn.2008.26352. View

20.

Demo E, Frush D, Gottfried M, Koepke J, Boney A, Bali D . Glycogen storage disease type III-hepatocellular carcinoma a long-term complication?. J Hepatol. 2007; 46(3):492-8. PMC: 2683272. DOI: 10.1016/j.jhep.2006.09.022. View